Literature DB >> 1990792

Hemodynamic and electrophysiologic evaluation of patients with hypertrophic cardiomyopathy surviving cardiac arrest.

L Fananapazir1, S E Epstein.   

Abstract

Hemodynamic and electrophysiologic studies were performed in 30 survivors of sudden cardiac arrest with hypertrophic cardiomyopathy (HC) to determine responsible factors. Electrophysiologic abnormalities alone were present in 27 patients (90%): sinus node dysfunction in 14 (47%), delayed atrio-ventricular nodal conduction in 1 (3%), abnormal His-Purkinje conduction in 7 (23%), an inducible atrial tachycardia in 7 (23%), and inducible sustained ventricular arrhythmia in 21 (70%). Sustained ventricular arrhythmia was polymorphic ventricular tachycardia (VT) in 18 patients (86%), monomorphic VT in 2 patients (7%) and ventricular fibrillation in 1 patient (3%). In 1 patient the arrhythmia recorded during an episode of cardiac arrest and induced at electrophysiologic study was polymorphic VT. VT was induced with less than or equal to 2 extra-stimuli in only 1 patient (3%) but with less than or equal to 3 extra-stimuli in 20 patients (97%). Potential causes of sudden cardiac arrest were found in all patients and were multiple in 13 patients (43%). These were (1) ventricular electrical instability in 21 patients (70%), (2) severe left ventricular outflow tract obstruction in 8 patients (27%), (3) bradycardia in 5 patients (17%), (4) myocardial ischemia associated with hypotension in 5 patients (17%), and (5) atrial tachycardia resulting in hypotension in 4 patients (13%). Of the 21 patients with inducible sustained ventricular arrhythmia, 17 received an implantable defibrillator device and 4 were treated with antiarrhythmic drugs. Seven patients underwent left ventricular septal myectomy.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1990792     DOI: 10.1016/0002-9149(91)90560-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Electrophysiological abnormalities and arrhythmias in alpha MHC mutant familial hypertrophic cardiomyopathy mice.

Authors:  C I Berul; M E Christe; M J Aronovitz; C E Seidman; J G Seidman; M E Mendelsohn
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

2.  Familial hypertrophic cardiomyopathy mice display gender differences in electrophysiological abnormalities.

Authors:  C I Berul; M E Christe; M J Aronovitz; C T Maguire; C E Seidman; J G Seidman; M E Mendelsohn
Journal:  J Interv Card Electrophysiol       Date:  1998-03       Impact factor: 1.900

3.  Systolic compression of epicardial coronary and intramural arteries in children with hypertrophic cardiomyopathy.

Authors:  Saidi A Mohiddin; Lameh Fananapazir
Journal:  Tex Heart Inst J       Date:  2002

4.  Cardiac arrest and hypertrophic cardiomyopathy. Role of the implantable defibrillator.

Authors:  D C Lefroy
Journal:  BMJ       Date:  1994-11-12

Review 5.  A primer on arrhythmias in patients with hypertrophic cardiomyopathy.

Authors:  Katy E Bockstall; Mark S Link
Journal:  Curr Cardiol Rep       Date:  2012-10       Impact factor: 2.931

6.  Cerebellar ataxia, seizures, premature death, and cardiac abnormalities in mice with targeted disruption of the Cacna2d2 gene.

Authors:  Sergey V Ivanov; Jerrold M Ward; Lino Tessarollo; Dorothea McAreavey; Vandana Sachdev; Lameh Fananapazir; Melissa K Banks; Nicole Morris; Draginja Djurickovic; Deborah E Devor-Henneman; Ming-Hui Wei; Gregory W Alvord; Boning Gao; James A Richardson; John D Minna; Michael A Rogawski; Michael I Lerman
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

7.  Future bradyarrhythmia in patients with hypertrophic cardiomyopathy.

Authors:  Kosuke Nakasuka; Shuichi Kitada; Yu Kawada; Marina Kato; Shohei Kikuchi; Yoshihiro Seo; Nobuyuki Ohte
Journal:  Int J Cardiol Heart Vasc       Date:  2021-02-26

8.  Hypertrophic Cardiomyopathy.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.